News
-
PPI higher risk link
Wednesday | Jul 5 2017A new study published in BMJ Open this week has suggested an increased risk of death among users of proton pump inhibitors (PPIs), based on records from more than six million patients that compared the use of PPIs, H2 blockers or neither treatment.
-
TGA EOFY survey
Wednesday | Jul 5 2017AT THE end of every financial year the Therapeutic Goods Administration (TGA) seeks feedback on its communications and consultation activities as well as its performance during the period of the financial year 2016/17.
-
Digital Hospitals book
Wednesday | Jul 5 2017STANDARDS Australia has this week published a world first Digital Hospitals Handbook which focuses on delivering more efficient hospital services through the use of technology.
-
Walker elected to Qld Guild
Wednesday | Jul 5 2017PHARMACY of the Year 2017 owner Lucy Walker (pictured) from Goondiwindi has been elected to the Queensland branch committee of the Pharmacy Guild of Australia.
-
-
Dispensary Corner 04 July 17
Tuesday | Jul 4 2017SOMETIMES Viagra can be expensive, according to Norway's Eigersund Mayor Odd Stangeland.
-
OTC Training Academy
Tuesday | Jul 4 2017NICHOLAS Hall and Xpotential will be exhibiting at the 2017 World Self Medication Industry General Assembly and running a one-day OTC Training Academy Workshop, to be held in Sydney on 20 Oct.
-
Pharmacist arrested
Tuesday | Jul 4 2017THE Western Australian Corruption and Crime Commission has published its report on Schedule 8 drugs resulting from the investigation of a pharmacist who had become highly addicted to a potent opioid drug (hydromorphone).
-
NIP expansion
Tuesday | Jul 4 2017EFFECTIVE 01 Jul the National Immunisation Program (NIP) is being expanded by the Federal Government to include more catch-up vaccines for people, including immigrants, to protect them against vaccine preventable diseases.
-
Fluorouracil a-flagged
Tuesday | Jul 4 2017APOC-5FU (fluorouracil 5% w/w cream) from Apotex is now listed on the RPBS effective 01 Jul as a-flagged and interchangeable with iNova Pharmaceuticals' Efudix for the treatment of solar and senile keratoses as well as Bowen's disease, the company has said.
